Will Fines Change Corporate Culture That Caused Opioid Crisis?
An Oklahoma judge order Johnson & Johnson (J&J) subsidiary Janssen Pharmaceuticals to pay a $572 million fine to the state for fueling the opioid crisis. This was the first case of its kind to go to trial and could influence similar claims by more than 40 states against the pharmaceutical industry. “As a matter of […]
Opioid Drugmakers May Be Liable Under Consumer Protection Laws
Philadelphia District Attorney Larry Krasner has been given approval by a state judge to move forward with with action against drugmakers and distributors for illegal marketing and sales of opioid painkillers resulting in a nationwide epidemic. The suit, a first of its kind, brings claims under Pennsylvania’s Unfair Trade Practices and Consumer Protection Law. The UTPCPL bans […]
Sheller on Thom Hartman Radio Show
From The Ring of Fire: Why Is Big Pharma Increasing Your Medicine Prices? By Thom Hartmann – July 17, 2019 The US pays more for medical drugs that in any country in the world. Health in the US is all about making a profit and drug prices have increased dramatically since Trump become president. Drug […]
New Trial for Risperdal Injury Previously Tossed
In another win for plaintiffs injured by Risperdal, a Pennsylvania appellate court reversed a trial courts decision to grant the defendants motion for nonsuit, mid-trial. This decision will send the case back to the Pennsylvania Courts of Common Pleas for retrial. In the 2016 case of T.M. vs Janssen Pharmaceuticals, the trial judge decided mid-trial […]
Oklahoma Sues J&J Over Opioid Crisis
Purdue Pharma is named the main defendant in multiple city, state and local lawsuits against the pharmaceutical companies that played a part in the current opioid crisis. The suits claim the drug maker’s aggressive marketing of its opioid painkiller OxyContin began the crisis more than two decades ago. News media has covered the crisis extensively, including John Oliver […]
Temple Law Honors Sheller with Doctor of Humane Letters
Attorney Stephen Sheller, founder of Sheller PC, was honored with a doctor of humane letters degree at Temple University’s Beasley School of Law 2019 Commencement Ceremony on May 16. The Beasley School of Law celebrates Stephen A. Sheller, founding and managing partner of Sheller, P.C. and a passionate advocate for underdog clients. His philanthropic support […]
April 23rd, Book Signing: Big Pharma Big Greed
When: Tuesday, April 23, 2019 Time: 5:30 PM Location: Shakespeare & Co., 1632 Walnut Street, Philadelphia, PA 19103 Description: Big Pharma, Big Greed: The Inside Story of One Lawyer’s Battle to Stem the Flood of Dangerous Medicines and Protect Public Health An update and expansion of Sheller’s previous book with Sidney Kirkpatrick “Pharmageddon: A […]
Record $240M Opioid Settlement Against Purdue Pharma
Purdue Pharma, makers of the opioid painkiller OxyContin, have settled with the state of Oklahoma for a record $240 million. This is Purdue’s third and largest state settlement yet. The drug manufacturer still faces thousands of other pending local, city and state suits, including a 1,600 case consolidated federal suit against Purdue and other drug manufacturers, […]
J&J CEO May Testify in Risperdal Trial
Updated January 30, 2019 The eighth Risperdal case is set to go to trial, this time the stakes are even higher for both sides as the jury may award punitive damages to the plaintiff if wrongful conduct by Johnson & Johnson is proven. “We’re excited about the availability of punitive damages. All along, we thought […]
Conflicts of Interest in Medical Research
In Stephen Sheller’s book Lawyering In Times of Saints and Evil Doers (2015), Sheller tells the story of science for sale, the widespread conflict of interest created when doctors and researchers are influenced by payments they receive from pharmaceutical companies. In 2008, a Congressional inquiry led by Senator Charles E. Grassley (R-IA) exposed the extensive conflict of interest […]
